New Marine-Inspired Oxadiazole Derivatives for Use Against Pancreatic Ductal Adenocarcinoma
Marine Drugs · 2025
DOI: 10.3390/md23080327 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, 2025. Verfasst von Camilla Pecoraro und 7 weiteren Autor:innen. Beteiligte Einrichtung: Dipartimento di Scienze e Tecnologie Biologiche Chimiche e Farmaceutiche (STEBICEF), Università Degli Studi di Palermo, Via Archirafi 32, 90123 Paler…. Hauptthemen laut MEDLINE: Oxadiazoles, Carcinoma, Pancreatic Ductal, Pancreatic Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of University and Research (MUR), Fondazione Pisa, Dutch Cancer Society.
Abstract (Originalsprache)
Pancreatic ductal adenocarcinoma (PDAC) remains one of the deadliest malignancies, with limited effective therapeutic options due to late diagnosis, aggressive progression, and rapid development of drug resistance. In pursuit of novel treatments, this study reports the design, synthesis, and biological evaluation of a new series of topsentin derivatives, featuring a 1,2,4-oxadiazole core. The newly synthesized derivatives were screened for antiproliferative activity against multiple PDAC cell lines (SUIT-2, Patu-T, and PANC-1), identifying several compounds with potent growth-inhibitory effects, particularly on SUIT-2 and Patu-T cells. Further studies demonstrated that these compounds also significantly inhibited cell migration and reduced clonogenic potential, with IC50 values in the micromolar range. The results suggest that these marine-inspired 1,2,4-oxadiazole derivatives effectively target key hallmarks of PDAC, including proliferation, migration, and colony formation, supporting their further development as promising candidates for overcoming drug resistance and metastatic progression in pancreatic cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Dipartimento di Scienze e Tecnologie Biologiche Chimiche e Farmaceutiche (STEBICEF), Università Degli Studi di Palermo, Via Archirafi 32, 90123 Palermo, Italy.
- Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, VU University Medical Center (VUmc), De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.
- Cancer Pharmacology Laboratory, Fondazione Pisana per la Scienza, Via Ferruccio Giovannini 13, San Giuliano Terme, 56017 Pisa, Italy.
ORCID-Profile: Camilla Pecoraro, Daniela Carbone, Fares Hezam Mohammed Al Ostoot, Patrizia Diana, Elisa Giovannetti, Barbara Parrino
Förderung
- Italian Ministry of University and Research (MUR)
- Fondazione Pisa
- Dutch Cancer Society
- AIRC
- COST (European Cooperation in Science and Technology)
Zitieren
APA
Pecoraro, C., Carbone, D., Al Ostoot, F. H. M., Vahabi, M., Lencioni, G., Diana, P., Giovannetti, E., & Parrino, B. (2025). New Marine-Inspired Oxadiazole Derivatives for Use Against Pancreatic Ductal Adenocarcinoma. Marine Drugs. https://doi.org/10.3390/md23080327
Vancouver
Pecoraro C, Carbone D, Al Ostoot FHM, Vahabi M, Lencioni G, Diana P, et al. New Marine-Inspired Oxadiazole Derivatives for Use Against Pancreatic Ductal Adenocarcinoma. Marine Drugs. 2025. doi:10.3390/md23080327
BibTeX
@article{Pecoraro2025,
author = {Pecoraro, Camilla and Carbone, Daniela and Al Ostoot, Fares Hezam Mohammed and Vahabi, Mahrou and Lencioni, Giulia and Diana, Patrizia and Giovannetti, Elisa and Parrino, Barbara},
title = {New Marine-Inspired Oxadiazole Derivatives for Use Against Pancreatic Ductal Adenocarcinoma},
journal = {Marine Drugs},
year = {2025},
doi = {10.3390/md23080327}
}
EUVIMED